These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2069116)

  • 21. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
    Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
    Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
    Kishi H; Kaneco H; Tominaga T; Niijima T; Nishimura Y; Saito I; Ishii Y; Nito H; Yuge J; Asano M
    Hinyokika Kiyo; 1984 Jan; 30(1):103-20. PubMed ID: 6375317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
    Honderlick P; Cahen P; Gravisse J; Vignon D
    Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viability and ultrastructure of S. aureus treated with fosfomycin.
    Schmid EN
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):476-88. PubMed ID: 6858443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience of norfloxacin (Baccidal) in the urological field].
    Fukuoka H; Goto A; Sasaki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1667-74. PubMed ID: 4083223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystocentesis is essential for reliable diagnosis of urinary tract infections in cats.
    van Duijkeren E; van Laar P; Houwers DJ
    Tijdschr Diergeneeskd; 2004 Jun; 129(12):394-6. PubMed ID: 15232961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections].
    Alós JI; García-Peña P; Tamayo J
    Rev Esp Quimioter; 2007 Jun; 20(2):211-5. PubMed ID: 17893758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet parameters in children with upper urinary tract infection: is there a specific response?
    Catal F; Bavbek N; Bayrak O; Uz E; Isik B; Karabel M; Degirmencioglu H; Mete E; Akcay A
    Ren Fail; 2008; 30(4):377-81. PubMed ID: 18569910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutoff values for bacteria and leukocytes for urine flow cytometer Sysmex UF-1000i in urinary tract infections.
    Manoni F; Fornasiero L; Ercolin M; Tinello A; Ferrian M; Hoffer P; Valverde S; Gessoni G
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):103-7. PubMed ID: 19748419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K; Nagata Y
    Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructure and viability of K. pneumoniae treated with fosfomycin.
    Schmid EN
    Zentralbl Bakteriol A; 1980 Aug; 247(3):339-46. PubMed ID: 6999801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
    Takaha M; Ichikawa Y; Sagawa S; Sonoda T; Nakamura T; Kotake T; Miki T; Yano H; Itatani H; Shin T
    Hinyokika Kiyo; 1984 Oct; 30(10):1519-29. PubMed ID: 6098179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens.
    Scarparo C; Piccoli P; Ricordi P; Scagnelli M
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):283-9. PubMed ID: 12072939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of fosfomycin urine and renal parenchyma levels in the treatment of urinary infections].
    Asteriti M; Bellini G; Cartolari L; Zoni G
    Boll Chim Farm; 1978 Oct; 117(10):575-82. PubMed ID: 743353
    [No Abstract]   [Full Text] [Related]  

  • 40. Fosfomycin: what was old is new again.
    Avent ML; Rogers BA; Cheng AC; Athan E; Francis JR; Roberts MJ; Paterson DL; Harris PNA
    Intern Med J; 2018 Dec; 48(12):1425-1429. PubMed ID: 30517987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.